Genetically altered animal models for ATP1A3-related disorders

Area of Science:

• Neuroscience
• Genetics
• Rare Diseases

Background:

• Mutations in ATP1A3, encoding the neuron-specific Na+,K+-ATPase α3 (NKA α3) pump, cause a spectrum of rare neurological disorders.
• These allelic disorders include polymicrogyria, alternating hemiplegia of childhood, and rapid-onset dystonia-parkinsonism, often presenting in childhood.
• Current treatments are limited, highlighting an urgent need for effective therapeutic strategies.

Purpose of the Study:

• To review existing animal models for studying ATP1A3-related neurological disorders.
• To discuss how these models can elucidate the molecular mechanisms underlying these conditions.
• To explore the potential of these models in developing novel therapeutics.

Main Methods:

• Review of existing literature on genetically altered model organisms.
• Comparative analysis of mouse, zebrafish, Drosophila, and Caenorhabditis elegans models.
• Assessment of model utility for studying NKA α3 pump dysfunction.

Main Results:

• Identified various animal models (mouse, zebrafish, Drosophila, C. elegans) for ATP1A3 disorders.
• Highlighted the utility of these models in studying the biological consequences of NKA α3 mutations.
• Demonstrated the potential of comparative studies in understanding disease pathogenesis.

Conclusions:

• Animal models are crucial for understanding the poorly understood molecular mechanisms of ATP1A3-related neurological disorders.
• These models offer valuable platforms for the development of targeted and effective therapies.
• Further research using these models is essential for advancing treatment options for patients.